We are proud to announce that Outsourced Pharma has honored us with their 14th Annual #CDMOLeadershipAwards! Determined by customers who utilize cell and gene delivery services, this award recognizes us as their most valued partners. ?? Thank you to all of our customers and fellow VectorBuilders who have joined us in the gene delivery revolution! ?? Check out our CDMO Services page on our website: https://lnkd.in/esh7kdRP
VectorBuilder
生物技术研究
Chicago，Illinois 6,480 位关注者
VectorBuilder is a global leader in gene delivery technologies.
关于我们
As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies. So we ask you one question: Will you join us in the gene delivery revolution？
- 网站
-
https://www.vectorbuilder.com/?utm_source=LinkedIn+Bio&utm_medium=banner&utm_campaign=LinkedIn+Page+Bio
VectorBuilder的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Chicago，Illinois
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Cloning、Virus Packaging、Vector Construction、BAC Recombineering、Lentivirus、Adenovirus、Adeno-associated virus、shRNA libraries、CRISPR、shRNA、Gene synthesis、GMP manufacturing、Cell Line Generation、COVID-19 products、CAR-T和HSV
地点
VectorBuilder员工
动态
-
Go beyond mere manufacturing with a CDMO partner that you can trust! ?? At VectorBuilder, we know that working with a CDMO isn’t just about production—it’s about trust, expertise, and long-term success. With CDMOs becoming increasingly interchangeable, the difference comes down to true problem-solving, reliability, and a scientist-driven approach: in other words, you need a partner who doesn't just manufacture but truly collaborates with you. That’s why our creed is simple: "Scientists Helping Scientists." ?? Whether it's overcoming manufacturing hurdles, optimizing vector design, or providing expert guidance, our team is here to take the burden off your shoulders. ? Visit our CDMO page today: https://lnkd.in/esh7kdRP
-
-
VectorBuilder is the future of gene delivery. Their mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. Their team strives to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. The “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, they have received growing customer testimonials and numerous citations in high-impact publications. ? Join the VectorBuilder team at the upcoming Chicago BioLife Summit on Wednesday, May 28th for a day of insightful panel discussions and ample networking opportunities! ? Check out the full speaker lineup and secure your spot at the summit here: https://lnkd.in/eyHFy4v4 ? Reach out to Natalie Ericson at [email protected] for more info!
-
-
Behind every breakthrough in medicine, diagnostics, and treatment, there are brilliant scientists working constantly to drive innovation and discovery. #HealthcareScienceWeek ?? This week at VectorBuilder, we celebrate the researchers, clinicians, and innovators shaping the future of healthcare through science. Explore how our cutting-edge gene delivery solutions are accelerating breakthroughs in biotech and medicine: www.VectorBuilder.com ??
-
-
Come visit our Territory Manager Nadine Müller, PhD at the DG-GT eV to learn how VectorBuilder can revolutionize your research! ??
Are you working on ?Gene Editing towards Therapies“? Then meet us at the DG-GT Theme day in Dresden today and tomorrow! I look forward to the great talks, posters and discussing your projects at our booth at the German Hygiene Museum.
-
-
Our seminar will be going live in TEN MINUTES! ? Register now to be the first to learn about the latest advancements in gene editing tools from Dr. Iuri Viotti Perisse: https://lnkd.in/e_nGCFih ?
Join us on Thursday, March 6?to hear Dr. Iuri Viotti Perisse from Utah State University discuss gene editing in large animals to create ideal models for human disease and agriculture. ? Register now: https://lnkd.in/e_nGCFih In this presentation, Dr. Viotti Perisse will discuss the latest advancements in gene editing tools that are enhancing the CRISPR-Cas9 toolbox and discuss novel genetic engineering strategies for the targeted integration of genes of interest into safe harbor loci, with a focus on their application in producing transgenic sheep and cattle. ??
-
-
Heading to the “granddaddy” of all cell and gene therapy conferences in Europe! ?? Stop by the Advanced Therapies Congress and get your CGT kicks in with Head of CDMO Global Operations Alan Griffith Ph.D, Head of CDMO Business Development Andrew Alcock, & Application Scientist Min Wen Ku! ?? When: March 18 - 19 ?? Where: ExCel, London More details coming soon!
-
-
?? Only two more days left to register for the next installment of our Gene Delivery Seminar Series. Click the link below to reserve your spot and let Dr. Iuri Viotti Perisse guide you in the use of CRISPR in large animal model systems! ? Register now: https://lnkd.in/e_nGCFih
-
-
Today is #RareDiseaseDay! ??? Over 300 million people worldwide are affected by rare diseases, most of which have very limited treatments. At VectorBuilder, we’re committed to advancing gene therapy and drug development to bring hope to patients and families. A recent milestone: One of our collaborators, Lantu Biopharma, received FDA Orphan Drug Designation for a therapy targeting #Menkes disease—a rare and life-threatening disorder affecting copper metabolism—accelerating the process towards an effective treatment. ?? Learn more: https://lnkd.in/g5Wbntqs #GeneTherapy #MenkesDisease #Biotech #VectorBuilder #Rare #GeneDelivery
-
-
Territory Manager at VectorBuilder Inc. (Australia & Asia Pacific) "Providing Gene Delivery Solutions to Drive Scientific Innovation"
A Science-Filled Reunion at Monash! ???? Had a fantastic afternoon visiting Monash University, Australian Regenerative Medicine Institute and the Biomedicine Discovery Institute, catching up with some old colleagues, and diving into some great scientific discussions. It’s always inspiring to reconnect and see how research has evolved over the years! ?? Even better—along the way, I ran into some of VectorBuilder’s customers and saw firsthand how we’ve grown alongside them. From custom vector design to gene delivery solutions, it’s rewarding to know that our technology is helping researchers push their discoveries forward. Science is all about collaboration, and I love seeing how VectorBuilder continues to support innovation in labs like these. Looking forward to more visits and more breakthroughs ahead! ???? #MonashUniversity #ARMI #BDI #Science #GeneDelivery #CRISPR #VectorDesign #VectorBuilder #Biotech #Collaboration
-